How Credit Suisse Currently Rates UnitedHealth (NYSE:UNH)
In a note distributed to Clients on Wednesday, 16 December, Credit Suisse analyst just started coverage of UnitedHealth (NYSE:UNH) with “Outperform” rating.
From a total of 22 analysts covering UnitedHealth Group (NYSE:UNH) stock, 20 rate it a ”Buy”, 0 a “Sell”, and 3 a ”Hold”. This means that 87% of the ratings are positive. The highest target price is $172 while the lowest target price is $130. The mean of all analyst targets is $142.55 with a 15.87% above today’s ($118.88) stock price. UnitedHealth Group was the topic of 12 analyst reports since September 2, 2015 according to the firm StockzIntelligence Inc. Mizuho maintained shares on November 20 with “Buy” rating. Citigroup initiated UNH stock in a recent report from October 2 with “Buy” rating. Finally, Vetr upgraded the stock to “Strong-Buy” rating in a report issued on a September 2.
Approximately 849,209 shares of stock traded hands. UnitedHealth Group Inc (NYSE:UNH) has risen 1.51% since May 13, 2015 and is uptrending. It has outperformed by 4.13% the S&P500.
The overall sentiment of institutions has increased to 1.1 in Q2 2015. Its up 0.05, from 1.05 in 2015Q2. The ratio improved, as 80 institutions have sold all the shares of UnitedHealth Group Inc that they owned while 412 funds have taken shares off the table. 85 funds have purchased shares for the first time while 455 added to their positions. These institutions now hold 771.23 million shares or 5.85% less than the 819.16 million shares they owned in 2015Q2.
The Fund Garrison Bradford & Associates Inc currently is holding shares equating to 13.47% of its total portfolio in UnitedHealth Group Inc representing a total of 105,201 shares. Another fund,Veritas Investment Management Llp, is holding a total of 455,480 shares equating to 12.13% of their holdings. Additionally, Veritas Investment Management (Uk) Ltd has a 148,558 share stake in UnitedHealth Group Inc which represents 10.78% of their total portfolio. The Fund, Nevsky Capital Llp, based out of United Kingdom, has also built up a stake in the stock, which represents a total of 8.14% of their total portfolio. Finally Veritas Asset Management Llp, a fund which is based in the state of United Kingdom reported a total holdings of 4.75 million shares.
Insider activity is a very important aspect to track on any stock. Going back to March 20, 2015, shareholders of UnitedHealth Group Inc have witnessed 0 insider buys, and a total of 2 selling transactions equating to a net activity of approximately $7.10 million . Burke Richard T sold 50,000 shares worth approximately $5.88M. Ballard William C Jr sold 10,000 shares worth approximately $1.22 million. Wilensky Gail R sold 20,620 shares worth approximately $2.45 million. Wilson D Ellen sold 3,300 shares worth approximately $394,284.
UnitedHealth Group Incorporated is a health and well-being company. The company has a market cap of $111.53 billion. The Company’s business platforms include UnitedHealthcare and Optum. It has 19.05 P/E ratio. UnitedHealthcare provides health care benefits to various clients and markets.
According to Zacks Investment Research, “UnitedHealth Group Inc. offers health care coverage and related services to help people achieve improved health and well-being through all stages of life. The company’s products and services reflect a number of core capabilities, including medical information management, health benefit administration, care coordination, risk assessment and pricing, health benefit design and provider contracting. With these capabilities, it is able to provide comprehensive health care management services through organized health systems and insurance products.”